Krystal Biotech Inc header image

Krystal Biotech Inc

KRYS

Equity

ISIN null / Valor 38026052

NASDAQ (2026-03-05)

USD 260.33-1.76%

Krystal Biotech Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Krystal Biotech Inc is a biotechnology company that specializes in developing gene therapies for various genetic diseases. Their first commercial product, VYJUVEK®, is a redosable gene therapy designed to treat dystrophic epidermolysis bullosa. The company is focused on advancing innovative treatments that address unmet medical needs in the field of genetic disorders.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

44.6%1Y

229%3Y

258%5Y

Performance

43.5%1Y

49.5%3Y

62.6%5Y

Volatility

7610 M

Market cap (USD)

276,513

Daily traded volume (Shares)

160.055 / 154.99

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Conmed Corp

Conmed Corp Valor: 920278

Annual Return

-50%0%+50%

Risk level

110

-3.70%USD 41.40

National Healthcare Corp

National Healthcare Corp Valor: 836282

Annual Return

-50%0%+50%

Risk level

110

-2.74%USD 168.09

Dexcom Inc

Dexcom Inc Valor: 2107726

Annual Return

-50%0%+50%

Risk level

110

-3.03%USD 70.69

Insulet Corp

Insulet Corp Valor: 2941247

Annual Return

-50%0%+50%

Risk level

110

-0.80%USD 240.94

Henry Schein Inc

Henry Schein Inc Valor: 83527

Annual Return

-50%0%+50%

Risk level

110

-0.51%USD 80.17

NovoCure Limited

NovoCure Limited Valor: 29570025

Annual Return

-50%0%+50%

Risk level

110

6.04%USD 14.23

Roivant Sciences Limited

Roivant Sciences Limited Valor: 113331044

Annual Return

-50%0%+50%

Risk level

110

0.68%USD 29.72

Integra Lifesciences Holdings Corp

Integra Lifesciences Holdings Corp Valor: 912247

Annual Return

-50%0%+50%

Risk level

110

-4.81%USD 9.89

ICU Medical Inc

ICU Medical Inc Valor: 940704

Annual Return

-50%0%+50%

Risk level

110

-4.02%USD 136.74

CRISPR Therapeutics Ltd

CRISPR Therapeutics Ltd Valor: 33408113

Annual Return

-50%0%+50%

Risk level

110

-4.45%USD 57.33

SIX

FactSet

Clearbit

Logos provided by Clearbit